The T antigen locus of merkel cell polyomavirus downregulates human toll-like receptor 9 expression

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 13009-13019

  Shahzad, Naveed ^a   Shuda, Masahiro ^c   Gheit, Tarik ^a   Kwun, Hyun Jin ^c   Cornet, Iris ^a   Saidj, Djamel ^a   Zannetti, Claudia ^b   Hasan, Uzma ^b   Chang, Yuan ^c   Moore, Patrick S ^c   Accardi, Rosita ^a   Tommasino, Massimo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; MESSENGER RNA; TOLL LIKE RECEPTOR 9; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN;

ARTICLE; BK VIRUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; JC VIRUS; MERKEL CELL; MERKEL CELL POLYOMAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; UPREGULATION; VIRUS GENE;

ANTIGENS, VIRAL, TUMOR; CARCINOMA, MERKEL CELL; DOWN-REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MERKEL CELL POLYOMAVIRUS; MERKEL CELLS; POLYOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; TOLL-LIKE RECEPTOR 9; TUMOR VIRUS INFECTIONS;

EID: 84887152971     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01786-13     Document Type: Article

References (48)

1. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
2. Lemos B, Nghiem P. 2007. Merkel cell carcinoma:more deaths but still no pathway to blame. J. Invest. Dermatol. 127:2100-2103.
3. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. U.S.A. 105:16272-16277.
4. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS. 2009. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 125:1250-1256.
5. Touze A, Gaitan J, Arnold F, Cazal R, Fleury MJ, Combelas N, Sizaret PY, Guyetant S, Maruani A, Baay M, Tognon M, Coursaget P. 2010. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J. Clin. Microbiol. 48:1767-1770.
6. Kwun HJ, Guastafierro A, Shuda M, Meinke G, Bohm A, Moore PS, Chang Y. 2009. The minimum replication origin of Merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J. Virol. 83:12118-12128.
7. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC. 2010. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 84: 7064-7072.
8. Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N. 2009. Merkel cell carcinoma of the skin:pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol. 218:48-56.
9. Cheng J, Rozenblatt-Rosen O, Paulson KG, Nghiem P, DeCaprio JA. 2013. Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities. J. Virol. 87:6118-6126.
10. Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J. 2013. Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J. Virol. 87:9173-9188.
11. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. 2011. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 121:3623-3634.
12. Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D. 2010. Impaired Toll-like receptor 7 and 9 signaling:from chronic viral infections to cancer. Trends Immunol. 31:391-397.
13. Stanley MA. 2012. Epithelial cell responses to infection with human papillomavirus. Clin. Microbiol. Rev. 25:215-222.
14. Sathish N, Yuan Y. 2011. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus:an overview. J. Virol. 85:10934-10944.
15. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. 2010. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 5:1349-1365.
16. Moore PS, Chang Y. 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis:two sides of the same coin? Annu. Rev. Microbiol. 57:609-639.
17. Hasan UA, Zannetti C, Parroche P, Goutagny N, Malfroy M, Roblot G, Carreira C, Hussain I, Muller M, Taylor-Papadimitriou J, Picard D, Sylla BS, Trinchieri G, Medzhitov R, Tommasino M. 2013. The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J. Exp. Med. 210:1369-1387.
18. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145.
19. Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.
20. Beutler B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263.
21. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK, Eck M. 2004. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 136:521-526.
22. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM. 2004. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173:1179-1183.
23. Wagner H. 2004. The immunobiology of the TLR9 subfamily. Trends Immunol. 25:381-386.
24. Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, Yue J, Manet E, Tommasino M, Sylla BS, Hasan UA. 2010. EBV latent membrane protein 1 is a negative regulator of TLR9. J. Immunol. 185:6439-6447.
25. van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME. 2011. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J. Immunol. 186:1694-1702.
26. Martin HJ, Lee JM, Walls D, Hayward SD. 2007. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J. Virol. 81: 9748-9758.
27. Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T, Sideri M, Stubenrauch F, Tommasino M. 2007. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 178:3186-3197.
28. Vincent IE, Zannetti C, Lucifora J, Norder H, Protzer U, Hainaut P, Zoulim F, Tommasino M, Trepo C, Hasan U, Chemin I. 2011. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One 6:e26315. doi:10.1371/journal.pone.0026315.
29. Chang Y, Moore PS. 2012. Merkel cell carcinoma:a virus-induced human cancer. Annu. Rev. Pathol. 7:123-144.
30. Siebrasse EA, Reyes A, Lim ES, Zhao G, Mkakosya RS, Manary MJ, Gordon JI, Wang D. 2012. Identification of MW polyomavirus, a novel polyomavirus in human stool. J. Virol. 86:10321-10326.
31. Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman DM, Ishii KJ. 2004. Transcriptional regulation of the human TLR9 gene. J. Immunol. 173: 2552-2561.
32. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77:2195-2206.
33. Accardi R, Scalise M, Gheit T, Hussain IS, Yue J, Carreira C, Collino A, Indiveri C, Gissmann L, Sylla BS, Tommasino M. 2011. IκB kinase β promotes cell survival by antagonizing p53 functions through ΔNp73α phosphorylation and stabilization. Mol. Cell. Biol. 31:2210-2226.
34. Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, Gabet AS, Sylla BS, Gissmann L, Hainaut P, Tommasino M. 2006. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep. 7:334-340.
35. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. 2000. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Invest. Dermatol. 114:444-455.
36. Zannetti C, Bonnay F, Takeshita F, Parroche P, Menetrier-Caux C, Tommasino M, Hasan UA. 2010. C/EBPδ and STAT-1 are required for TLR8 transcriptional activity. J. Biol. Chem. 285:34773-34780.
37. Jiang C, Xuan Z, Zhao F, Zhang MQ. 2007. TRED:a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 35:D137-D140.
38. Java A, Cheng X, Brennan DC. 2012. Polyomavirus infections of humans. John Wiley & Sons, Ltd, Chichester, United Kingdom.
39. Arora R, Chang Y, Moore PS. 2012. MCV and Merkel cell carcinoma:a molecular success story. Curr. Opin. Virol. 2:489-498.
40. Li H, Gade P, Xiao W, Kalvakolanu DV. 2007. The interferon signaling network and transcription factor C/EBP-beta. Cell. Mol. Immunol. 4:407-418.
41. Nerlov C. 2007. The C/EBP family of transcription factors:a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17:318-324.
42. Schuster MB, Porse BT. 2006. C/EBPalpha:a tumour suppressor in multiple tissues? Biochim. Biophys. Acta 1766:88-103.
43. Johnson PF. 2005. Molecular stop signs:regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118:2545-2555.
44. Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS, Hayward SD. 2006. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J. Virol. 80:1098-1109.
45. Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del VL, Safak M, Khalili K, White MK. 2009. Modulation of JC virus transcription by C/EBPbeta. Virus Res. 146:97-106.
46. Sperling T, Oldak M, Walch-Ruckheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S. 2012. Human papillomavirus type 8 interferes with a novel C/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. PLoS Pathog. 8:e1002833. doi:10.1371/journal.ppat.1002833.
47. Müller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A. 1999. Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways. Proc. Natl. Acad. Sci. U.S.A. 96:7276-7281.
48. Kwun HJ, Shuda M, Feng H, Camacho CJ, Moore PS, Chang Y. 2013. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCF(Fbw7.). Cell Host Microbe 14:125-135.